How much revenue did Hepion Pharmaceuticals generate this year?
Hepion Pharmaceuticals has achieved a revenue of 0 USD this year.
Hepion Pharmaceuticals Revenue 2024
Hepion Pharmaceuticals Revenue
0 USD
Hepion Pharmaceuticals Dividend yield
Ticker
HEPA
ISIN
US4268971045
WKN
A2PN6W
In 2024, Hepion Pharmaceuticals's sales reached 0 USD, a 0% difference from the 0 USD sales recorded in the previous year.
The Hepion Pharmaceuticals Revenue history
| YEAR | REVENUE (undefined USD) | GROSS MARGIN (%) |
|---|---|---|
| 2030e | - | - |
| 2029e | - | - |
| 2028e | - | - |
| 2027e | - | - |
| 2026e | - | - |
| 2025e | - | - |
| 2024e | - | - |
| 2023 | - | - |
| 2022 | - | - |
| 2021 | - | - |
| 2020 | - | - |
| 2019 | - | - |
| 2018 | - | - |
| 2017 | - | - |
| 2016 | - | - |
| 2015 | - | - |
| 2014 | - | - |
| 2013 | - | - |
| 2012 | - | - |
Hepion Pharmaceuticals Aktienanalyse
What does Hepion Pharmaceuticals do?
Hepion Pharmaceuticals Inc. is a biopharmaceutical company focused on researching and developing therapeutics for the treatment of liver diseases. The company was founded in 2013 and is headquartered in Edison, New Jersey. The history of Hepion Pharmaceuticals Inc. began with the discovery of a new approach to treating liver diseases. Researchers found that small molecules targeting specific cells in the liver could have a positive effect on liver function. Hepion used this discovery as a starting point for developing new drugs to treat liver diseases. Hepion Pharmaceuticals Inc.'s business model is based on the development and marketing of innovative therapeutics for a variety of liver diseases, including fatty liver disease, alcoholic liver disease, non-alcoholic steatohepatitis (NASH), liver fibrosis, liver cirrhosis, and liver cancer. Hepion Pharmaceuticals has several divisions, all focused on the development of therapeutics for liver diseases. The primary division is research and development, which focuses on identifying and developing new drugs for the liver. Another important division is clinical development, where the drugs are tested and validated in clinical trials. The third division is marketing, where the therapeutics are marketed and sold. Hepion Pharmaceuticals Inc. currently offers two products. The first product is CRV431, a top-notch inhibitor of cytokine-mediated signaling. It is an orally administered drug specifically developed for the treatment of liver fibrosis. CRV431 aims to inhibit cytokine-mediated signaling responsible for fibrosis formation. The second product is an idiosyncratic database marketed under the name AI-Enabler. It is touted by the company as a groundbreaking tool for more precise medicine and research in support of drug development work. Overall, Hepion Pharmaceuticals Inc. is a promising biopharma company with a clear focus on developing new drugs for the treatment of liver diseases. With its innovative products and expertise in research and development, the company collaborates closely with partners from the scientific, industrial, and governmental sectors. It is hoped that this company will make further pioneering discoveries in the future and contribute to the benefit of human health. Hepion Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding Hepion Pharmaceuticals's Sales Figures
The sales figures of Hepion Pharmaceuticals originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing Hepion Pharmaceuticals’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize Hepion Pharmaceuticals's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in Hepion Pharmaceuticals’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about Hepion Pharmaceuticals Stock
How much was the turnover of the company Hepion Pharmaceuticals compared to the previous year?
The revenue of Hepion Pharmaceuticals has increased by 0% decreased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of Hepion Pharmaceuticals?
The revenue of Hepion Pharmaceuticals is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of Hepion Pharmaceuticals measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of Hepion Pharmaceuticals so important for investors?
The revenue of Hepion Pharmaceuticals is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does Hepion Pharmaceuticals pay?
Over the past 12 months, Hepion Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Hepion Pharmaceuticals is expected to pay a dividend of 0 USD.
What is the dividend yield of Hepion Pharmaceuticals?
The current dividend yield of Hepion Pharmaceuticals is .
When does Hepion Pharmaceuticals pay dividends?
Hepion Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Hepion Pharmaceuticals?
Hepion Pharmaceuticals paid dividends every year for the past 0 years.
What is the dividend of Hepion Pharmaceuticals?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Hepion Pharmaceuticals located?
Hepion Pharmaceuticals is assigned to the 'Health' sector.
Wann musste ich die Aktien von Hepion Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Hepion Pharmaceuticals from 5/12/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/12/2024.
When did Hepion Pharmaceuticals pay the last dividend?
The last dividend was paid out on 5/12/2024.
What was the dividend of Hepion Pharmaceuticals in the year 2023?
In the year 2023, Hepion Pharmaceuticals distributed 0 USD as dividends.
In which currency does Hepion Pharmaceuticals pay out the dividend?
The dividends of Hepion Pharmaceuticals are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Hepion Pharmaceuticals stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Hepion Pharmaceuticals
Our stock analysis for Hepion Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hepion Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Hepion Pharmaceuticals Revenue
- Hepion Pharmaceuticals Net Income
- Hepion Pharmaceuticals P/E
- Hepion Pharmaceuticals P/S
- Hepion Pharmaceuticals EBIT
- Hepion Pharmaceuticals Dividend
- Hepion Pharmaceuticals Stocks
- Hepion Pharmaceuticals Market capitalization
- Hepion Pharmaceuticals Debt
- Hepion Pharmaceuticals Liabilities
- Hepion Pharmaceuticals Equity
- Hepion Pharmaceuticals AAQS
- Hepion Pharmaceuticals Employees
- Hepion Pharmaceuticals ROE
- Hepion Pharmaceuticals ROA
- Hepion Pharmaceuticals ROCE
